112314 ⎘
Vector systems having a special element relevant for transcription from vertebrates mammalian
Adenoviral vectors having a protein IX deletion
#302Replication competent viruses capable of silencing virus inhibitory factor expression
#303TRANSGENIC MICE COMPRISING A GENOMIC HUMAN TAU TRANSGENE
#304Vigilant cells
#305Use of regulatory sequences for specific, transient expression in neuronal determined cells
#306Multiple gene transcription activity assay system
#307hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes
#308Vectors for tissue-specific replication
#309Method of treating or retarding the development of blindness
#310Gutless adenovirus vector and the construction method thereof
#311Liver specific chimeric regulatory sequence and use thereof
#312Methods of obtaining neural stem cells
#313Method for creating myeloid cell lines
#314Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
#315Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#316Delivery vehicle for recombinant proteins
#317Recombinant adenoviral vector and method of use
#318Transgenic rodents as animal models for modulation of B1 bradykinin receptor protein
#319Lysosomal proteins produced in the milk of transgenic animals
#320Adenoviral vectors having a protein IX deletion
#321Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases
#322Regulation of endogenous gene expression in cells using zinc finger proteins
#323Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
#324Adenoviral vectors having a protein IX deletion
#325Cell lines for production of replication-defective adenovirus
#326Gab2 (p97) gene and methods of use thereof
#327Tumour-cell specific gene expression and its use in cancer therapy
#328Production of hSA-linked butyrylcholinesterases in transgenic mammals
#329RNA polymerase III promoter, process for producing the same and method of using the same
#330Chromosome-based platforms
#331Cell-specific molecule and method for importing DNA into osteoblast nuclei
#332Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof
#333Adenoviral vectors having a protein IX deletion
#334Human prolyl isomerase 1 (PIN 1) promoter and uses thereof
#335Tr2, tr4, tr2/tr4 double knockouts and uses thereof
#336Transgenic animal as a model for fibrotic diseases
#337Multiple-compartment eukaryotic expression systems
#338Methods and vectors for improving nucleic acid expression
#339Gene trap system
#340Adenoviral vectors having a protein IX deletion
#341Method of screening antiobesity agents and animal model of obesity
#342Enhancement of adenoviral oncolytic activity by modification of the E1A gene product
#343Recombinant adenoviral vectors and methods of use
#344Episomal expression system
#345Sequences upstream of the CARP gene, vectors containing them and uses thereof
#346Method for the production of fusion proteins in transgenic mammal milk
#347Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
#348Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene
#349Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors
#350Adenoviral vectors having a protein IX deletion
#351Flavivirus expression and delivery system
#352Expression system for stem-loop rna molecule having rnai effect
#353Adiponectin promoter and use thereof
#354Gene reactivation by somatic hypermutation
#355Regulation of endogenous gene expression in cells using zinc finger proteins
#356Highly hypoxia-specific gene expression system for ischemic gene therapy
#357Hepatoma specific chimeric regulatory sequence
#358Nuclear factors associated with transcriptional regulation
#359Retinoic acid receptor beta-2, its agonists, and gene therapy vectors for the treatment of neurological disorders
#360Gene transcription and ionizing radiation: methods and compositions
#361AAV virions with decreased immunoreactivity and uses therefor
#362Adenoviral vectors having a protein IX deletion
#363Adenoviral vectors having a protein IX deletion
#364Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy
#365Chromosome-based platforms
#366Target cell-specific adenoviral vectors containing E3 and methods of use thereof
#367Selective killing of cancerous cells
#368Bovine immunodeficiency virus (BIV) based vectors
#369Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
#370Human GABAreceptor 1 promoters
#371AAV vectors for gene delivery to the lung
#372Transgenic animals expressing transglutaminase II
#373Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
#374Vectors for tissue-specific replication
#375Cancer - targeted viral vectors
#376Oncolytic adenoviral vectors encoding GM-CSF
#377Adeno-associated vector compositions for expression of Factor VIII
#378BMP-2 estrogen responsive element and methods of using the same
#379Molecular switch for regulating mammalian gene expression
#380Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins
#381Treatment of diabetes with synthetic beta cells
#382Novel clock gene promoter
#383Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
#384Transgenic non-human animals expressing a truncated activin type II receptor
#385Promoter sequences
#386Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
#387Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof
#388Host cells containing multiple integrating vectors comprising an amplifiable marker
#389Regulation of endogenous gene expression in cells using zinc finger proteins
#390Pan cancer oncolytic vectors and methods of use thereof
#391Means and methods for regulating gene expression
#392Bovine immunodeficiency virus (BIV) based vectors
#393Modulators of morphogen expression and methods of identifying the same
#394Method and cell composition for screening compounds for anti-inflammatory activity
#395Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
#396Production of recombinant polypeptides by bovine species and transgenic methods
#397Isolation, selection and propagation of animal transgenic stem cells
#398Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
#399DNA transfection system for the generation of infectious influenza virus
#400Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#401Oncolytic adenoviral vectors encoding GM-CSF
#402Chromosome-based platforms
#403Polynucleotide
#404Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
#405Prkag3 gene promoter and uses thereof
#406Expression vector
#407Method for comprehensive identification of cell lineage specific genes
#408Bovine immunodeficiency virus (BIV) based vectors
#409Bovine immunodeficiency virus (BIV) based vectors
#410Method of genetic screening using an amplifiable gene
#411In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
#412Regulation of endogenous gene expression in cells using zinc finger proteins
#413DNA construct for effecting homologous recombination and uses thereof
#414Hepatocellular carcinoma specific promoter and uses thereof
#415Dna vaccine
#416Packaging complementation cell-line for sv-40 vectors
#417Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
#418Method for identifying target epitopes of the T cell mediated immune response and for assaying epitope-specific T cells
#419Promoters exhibiting endothelial cell specificity and methods of using same
#420Methods of treating diabetes and other blood sugar disorders
#421Viral vector
#422Host cells containing multiple integrating vectors
#423Modified antibodies stably produced in milk and methods of producing same
#424Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
#425Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
#426Non-viral linear DNA vectors and methods for using the same
#427Expression vectors
#428Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
#429Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
#430Cell-specific expression/replication vector
#431Promoters to control cell differentiation
#432Tumor-specific promotor and use thereof
#433Nucleic acid constructs capable of high effeciency delivery of polynucleotides into dna containing organelles and methods of utilizing same
#434Transgenic animal model for cancer and stem cells
#435Use of the WAP or MMTV regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
#436Compositions for the derivation of germ cells from stem cells and methods of use thereof
#437ALK protein tyrosine kinase, cells and methods embodying and using same
#438Sequences upstream of the carp gene, vectors containing them and uses thereof
#439Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
#440Gene delivery system and methods of use
#441Method for producing transgenic animals